Show simple item record

dc.contributor.authorAshton, Lindsey
dc.contributor.authorLeather, Angela
dc.date.accessioned2021-08-17T12:22:39Z
dc.date.available2021-08-17T12:22:39Z
dc.date.issued2021en
dc.identifier.citationAshton L, Leather A. COVID-19 challenges-To the point of cell delivery - The reality. Bone Marrow Transplantation. 2021;56(SUPPL 1):353.en
dc.identifier.urihttp://hdl.handle.net/10541/624421
dc.description.abstractBackground: Here we intend to highlight the new challenges of organizing cell donation from a donor medical through to cell delivery at the Transplant centre during the COVID-19 pandemic. Activity within the Transplant program has been reduced in 2020 due to the Covid 19 pandemic. However this hasn’t come with a reduced work load. The Pandemic has presented Transplant teams with new challenges, hurdles and obstacles to consider. Methods: The donor is pivotal and the starting point of the allogeneic transplant. We are requiring more commitment from our donors in these unprecedented times. The risk of visiting a hospital environment from both an emotional and physical wellbeing. Weighing up the balance of protecting the donor and minimizing the risk. When to Screen, the number of Covid tests required. The additional inconvenience of isolating that’s required prior to donation. Financial cost, employer and family support. The guidelines are available for us to follow and interpret in addition to internal trust specific guidelines and policies, all of which are forever changing. Results: During the first 4 months of the pandemic being a treating cancer centre, we were unable to continue as a collection centre. There were concerns for donor and patient safety, capacity issues and staff numbers all considered too greater risk. We recommenced in September prior to the second outbreak and were faced with certain challenges. In 2019 we saw 99 unrelated donors of which 77 Proceeded to donate. From January to April 2020 when the pandemic started to hit and the service was put on hold, we saw 28 donors for medical and 20 donors proceeded to donate. Since, recommencing our service as a collection centre in September, we have been faced with new challenges. Two donors were found to be positive prior to donation. One at medical and the other post medical pre GCSF. Both resulted in a delayed transplant for the recipient, with additional support being required for the donors. We also experienced a positive Covid result after donation with uncertainty for the transplant centre if to use the cells— ultimately a transplant centre decision. Most harvested cells are being cryopreserved, increasing the risk of donated cells not been used. Throughout this process we are learning there are no easy answers. Further hurdles include Donors living overseas and the logistics of cell collection and time scales transporting the cells with bans and restrictions on travel, closed borders, cancelled flights and courier restrictions. Conclusions: How did we manage and overcome these challenges. At what cost? Psychological, physical and financial. For whose benefit? Donor, Recipient or both. This pandemic is forever evolving with no end in sight. We can only learn from what we know so far and improve on our practice supporting our donors at every step of their altruistic journey of their donation.en
dc.language.isoenen
dc.titleCOVID-19 challenges-To the point of cell delivery - The realityen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie Hospital, Manchesteren
dc.identifier.journalBone Marrow Transplantationen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record